The Effect of Interscalene Peripheral Nerve Block With 0.25% Bupivacaine vs 0.125% Bupivacaine on Lung Function
Information source: University of Utah
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Diaphragm Paralysis
Intervention: interscalene nerve block with 0.25% bupivacaine (Drug); interscalene block with 0.125% bupivacaine (Drug)
Phase: N/A
Status: Completed
Sponsored by: University of Utah Official(s) and/or principal investigator(s): Elizabeth Thackeray, MD, MPH, Principal Investigator, Affiliation: University of Utah Jeffrey Swenson, MD, Study Director, Affiliation: University of Utah
Summary
Peripheral nerve blocks are used to provide post-operative pain relief. Nerve blocks in the
neck, in the interscalene area, provide pain relief after shoulder surgery but can cause
temporary weakness or paralysis of the diaphragm. The investigators hypothesized that a
lower concentration of bupivacaine would cause less weakness of the diaphragm but still
provide good pain relief. Lung function and pain control was studied after interscalene
peripheral nerve block with 20 milliliters of 0. 25% bupivacaine or 0. 125% bupivacaine.
Clinical Details
Official title: Investigation Into the Effect of 0.25% Bupivacaine for Interscalene Peripheral Nerve Block vs 0.125% Bupivacaine on Pulmonary Function
Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Primary outcome: Abnormal Lung Function
Secondary outcome: Pain ReliefSatisfaction With Pain Control
Detailed description:
Prior to placement of interscalene brachial plexus peripheral nerve block (ISPNB), diaphragm
function was assessed using ultrasound as normal, no movement, or paradoxical. Room air
pulse oximetry (SpO2) was recorded. Patients were randomized to receive either 0. 25%
bupivacaine or 0. 125% bupivacaine. ISPNB was performed using a coded syringe of the study
drug, so that the anesthesiologists performing the nerve block, the patient, and the nurses
assessing the patient were blinded as to the concentration. Patients were given a general
endotracheal anesthesia for rotator cuff repair, and opioids were administered at the
discretion of the attending anesthesiologist. When patients met criteria for PACU
discharge, diaphragm function was again assessed using ultrasound and room air SpO2 was
recorded.
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- patients presenting for outpatient rotator cuff repair
- adults
- English as the primary language
Exclusion Criteria:
- evidence of peripheral nerve damage on affected side
- refusal of peripheral nerve block
- pregnant women
- lung disease, including obstructive sleep apnea
- chronic opioid use
- mental handicap
Locations and Contacts
University of Utah Orthopaedics Center, Salt Lake City, Utah 84108, United States
Additional Information
Starting date: May 2008
Last updated: December 9, 2013
|